GB0525535D0 - Tumour treatment - Google Patents

Tumour treatment

Info

Publication number
GB0525535D0
GB0525535D0 GBGB0525535.1A GB0525535A GB0525535D0 GB 0525535 D0 GB0525535 D0 GB 0525535D0 GB 0525535 A GB0525535 A GB 0525535A GB 0525535 D0 GB0525535 D0 GB 0525535D0
Authority
GB
United Kingdom
Prior art keywords
tumour treatment
tumour
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0525535.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CGT CORP
Original Assignee
CGT CORP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CGT CORP filed Critical CGT CORP
Priority to GBGB0525535.1A priority Critical patent/GB0525535D0/en
Publication of GB0525535D0 publication Critical patent/GB0525535D0/en
Priority to PCT/EP2006/012076 priority patent/WO2007068487A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A61K35/761—Adenovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GBGB0525535.1A 2005-12-15 2005-12-15 Tumour treatment Ceased GB0525535D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0525535.1A GB0525535D0 (en) 2005-12-15 2005-12-15 Tumour treatment
PCT/EP2006/012076 WO2007068487A2 (en) 2005-12-15 2006-12-14 Tumour treatment with treg down-regulating active agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0525535.1A GB0525535D0 (en) 2005-12-15 2005-12-15 Tumour treatment

Publications (1)

Publication Number Publication Date
GB0525535D0 true GB0525535D0 (en) 2006-01-25

Family

ID=35736181

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0525535.1A Ceased GB0525535D0 (en) 2005-12-15 2005-12-15 Tumour treatment

Country Status (2)

Country Link
GB (1) GB0525535D0 (en)
WO (1) WO2007068487A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10548957B2 (en) 2012-09-28 2020-02-04 Dana-Farber Cancer Institute, Inc. Targeted expansion of Qa-1-peptide-specific regulatory CD8 T cells to ameliorate arthritis
AU2013329372B2 (en) 2012-10-08 2018-07-12 St. Jude Children's Research Hospital Therapies based on control of regulatory T cell stability and function via a Neuropilin-1:Semaphorin axis
EP3302548A4 (en) * 2015-06-03 2019-01-02 Dana Farber Cancer Institute, Inc. Methods to induce conversion of regulatory t cells into effector t cells for cancer immunotherapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7182942B2 (en) * 2000-10-27 2007-02-27 Irx Therapeutics, Inc. Vaccine immunotherapy for immune suppressed patients
CA2516028C (en) * 2003-02-14 2012-10-16 University Of Southern California Conjugates comprising a cancer targeting molecule linked to a liver-expressed chemokine

Also Published As

Publication number Publication date
WO2007068487A3 (en) 2007-08-02
WO2007068487A2 (en) 2007-06-21

Similar Documents

Publication Publication Date Title
HK1205935A1 (en) Non-lithotripsic kidney-stone therapy
ZA200805877B (en) Pyridiazinone derivatives for tumour treatment
ZA200800907B (en) Treatment of cancer
IL188430A0 (en) Treatment of tumors
GB0506759D0 (en) Combination treatment methods
GB0504206D0 (en) Combination therapy
GB0509052D0 (en) Combination therapy
GB0516068D0 (en) Well treatment
GB0525540D0 (en) New treatment
GB0517387D0 (en) Combinations for the treatment of cancer
GB0511769D0 (en) Treatment
GB0428187D0 (en) Cancer treatment
IL187792A0 (en) 4-anilino-3-quinolinecarbonitriles for the treatment of cancer
GB0502171D0 (en) Well treatment
GB0520067D0 (en) Treatment of cancer
GB0525535D0 (en) Tumour treatment
ZA200805522B (en) Dioxoiane dérivates for the treatment of cancer
GB0507685D0 (en) Cancer treatment
GB0404675D0 (en) Cancer treatment
GB0517386D0 (en) Combinations for the treatment of cancer
GB0710871D0 (en) Cancer treatment
GB0505045D0 (en) Cancer treatment
GB0510770D0 (en) Cancer treatment
GB0505773D0 (en) Cancer treatment
GB0503566D0 (en) Treatment for cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)